Novo Nordisk to invest $158 million in insulin plant in Brazil

Brazil’s Supreme Court said lawyers representing X failed to pay outstanding fines to the wrong bank, postponing its decision on whether to allow the tech firm to resume services in Brazil. The payment of the fines is the only outstanding measure required by the court to allow X to operate in Brazil again.

Compartir esta publicacion: